Dysbiosis signature of mycobiota in colon polyp and colorectal cancer

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 36, Issue 12, 2017, Pages 2457-2468

  Gao, R ^a,b   Kong, C ^a,b   Li, H ^a,b   Huang, L ^a,b   Qu, X ^a,b   Qin, N ^b   Qin, H ^a,b  

^a TENTH PEOPLE S HOSPITAL OF TONGJI UNIVERSITY   (China)

^b TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALTERNARIA; ARTICLE; ASCOMYCETES; ASPERGILLUS; AUREOBASIDIUM; BASIDIOMYCETES; BIODIVERSITY; BUDDING YEAST; CANCER GROWTH; CANCER PATIENT; CANCER STAGING; CANDIDA; CARCINOGENESIS; CHYTRIDIOMYCETES; CLADORRHINUM; CLADOSPORIUM HERBARUM; COLON POLYP; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATION COEFFICIENT; DEBARYOMYCES; DISEASE ASSOCIATION; DOTHIDEOMYCETES; DYSBIOSIS; ENTYLOMATACEAE; EVALUATION STUDY; FECES ANALYSIS; FECES MICROFLORA; FEMALE; FILOBASIDIELLA; FUNGUS; GLOMEROMYCOTA; GLOMUS (FUNGUS); HUMAN; HUMICOLA; INOCYBACEAE; INOCYBE; INTESTINE FLORA; LASIOSPHAERIACEAE; MAJOR CLINICAL STUDY; MALASSEZIA; MALE; MICROASCACEAE; MICROASCALES; MICROBIAL COMMUNITY; MICROBIAL DIVERSITY; MIDDLE AGED; MUCOR; NONHUMAN; ORBILIOMYCETES; PENICILLIUM; PHENOTYPE; PRIORITY JOURNAL; PSEUDOLAGAROBASIDIUM; PSEUDOZYMA; PYRONEMATACEAE; SACCHAROMYCES; SORDARIACEAE; SORDARIALES; SORDARIOMYCETES; SPECIES COMPOSITION; TALAROMYCES; TRAMETES; TRICHOSPORON; USTILAGINALES; USTILAGINOMYCETES; ZYGOMYCETES; AGED; CLASSIFICATION; COLORECTAL TUMOR; DISEASE PREDISPOSITION; FECES; METAGENOME; METAGENOMICS; MICROBIOLOGY; PATHOLOGY; PROCEDURES; TUMOR VOLUME;

AGED; BIODIVERSITY; COLONIC POLYPS; COLORECTAL NEOPLASMS; DISEASE SUSCEPTIBILITY; DYSBIOSIS; FECES; FEMALE; FUNGI; GASTROINTESTINAL MICROBIOME; HUMANS; MALE; METAGENOME; METAGENOMICS; MIDDLE AGED; NEOPLASM STAGING; TUMOR BURDEN;

EID: 85027698493     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-017-3085-6     Document Type: Article

References (60)

1. Siegel RL, Miller KD, Jemal A (2017) Cancer Statistics, 2017. CA Cancer J Clin 67(1):7–30
2. Cunningham D, Atkin W, Lenz HJ, Lynch HT, Minsky B, Nordlinger B, Starling N (2010) Colorectal cancer. Lancet 375(9719):1030–1047
3. Collins D, Hogan AM, Winter DC (2011) Microbial and viral pathogens in colorectal cancer. Lancet Oncol 12(5):504–512
4. Kamada N, Chen GY, Inohara N, Núñez G (2013) Control of pathogens and pathobionts by the gut microbiota. Nat Immunol 14(7):685–690
5. Rooks MG, Garrett WS (2016) Gut microbiota, metabolites and host immunity. Nat Rev Immunol 16(6):341–352
6. Round JL, Mazmanian SK (2009) The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol 9(5):313–323
7. Ohtani N, Yoshimoto S, Hara E (2014) Obesity and cancer: a gut microbial connection. Cancer Res 74(7):1885–1889
8. Karlsson FH, Tremaroli V, Nookaew I, Bergström G, Behre CJ, Fagerberg B, Nielsen J, Bäckhed F (2013) Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature 498(7452):99–103
9. Qin J, Li Y, Cai Z, Li S, Zhu J, Zhang F, Liang S, Zhang W, Guan Y, Shen D, Peng Y, Zhang D, Jie Z, Wu W, Qin Y, Xue W, Li J, Han L, Lu D, Wu P, Dai Y, Sun X, Li Z, Tang A, Zhong S, Li X, Chen W, Xu R, Wang M, Feng Q, Gong M, Yu J, Zhang Y, Zhang M, Hansen T, Sanchez G, Raes J, Falony G, Okuda S, Almeida M, LeChatelier E, Renault P, Pons N, Batto JM, Zhang Z, Chen H, Yang R, Zheng W, Li S, Yang H, Wang J, Ehrlich SD, Nielsen R, Pedersen O, Kristiansen K, Wang J (2012) A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490(7418):55–60
10. Tang WH, Kitai T, Hazen SL (2017) Gut microbiota in cardiovascular health and disease. Circ Res 120(7):1183–1196
11. Strati F, Cavalieri D, Albanese D, De Felice C, Donati C, Hayek J, Jousson O, Leoncini S, Renzi D, Calabrò A, De Filippo C (2017) New evidences on the altered gut microbiota in autism spectrum disorders. Microbiome 5(1):24
12. Tian H, Ge X, Nie Y, Yang L, Ding C, McFarland LV, Zhang X, Chen Q, Gong J, Li N (2017) Fecal microbiota transplantation in patients with slow-transit constipation: a randomized, clinical trial. PLoS One 12(2):e0171308
13. Qin N, Yang F, Li A, Prifti E, Chen Y, Shao L, Guo J, Le Chatelier E, Yao J, Wu L, Zhou J, Ni S, Liu L, Pons N, Batto JM, Kennedy SP, Leonard P, Yuan C, Ding W, Chen Y, Hu X, Zheng B, Qian G, Xu W, Ehrlich SD, Zheng S, Li L (2014) Alterations of the human gut microbiome in liver cirrhosis. Nature 513(7516):59–64
14. Imhann F, Vich Vila A, Bonder MJ, Fu J, Gevers D, Visschedijk MC, Spekhorst LM, Alberts R, Franke L, van Dullemen HM, Ter Steege RW, Huttenhower C, Dijkstra G, Xavier RJ, Festen EA, Wijmenga C, Zhernakova A, Weersma RK (2016) Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease. Gut. doi:10.1136/gutjnl-2016-312135
15. Plottel CS, Blaser MJ (2011) Microbiome and malignancy. Cell Host Microbe 10(4):324–335
16. Shanahan F (2013) The colonic microbiota in health and disease. Curr Opin Gastroenterol 29(1):49–54
17. Feng Q, Liang S, Jia H, Stadlmayr A, Tang L, Lan Z, Zhang D, Xia H, Xu X, Jie Z, Su L, Li X, Li X, Li J, Xiao L, Huber-Schönauer U, Niederseer D, Xu X, Al-Aama JY, Yang H, Wang J, Kristiansen K, Arumugam M, Tilg H, Datz C, Wang J (2015) Gut microbiome development along the colorectal adenoma-carcinoma sequence. Nat Commun 6:6528
18. Flemer B, Lynch DB, Brown JM, Jeffery IB, Ryan FJ, Claesson MJ, O’Riordain M, Shanahan F, O’Toole PW (2017) Tumour-associated and non-tumour-associated microbiota in colorectal cancer. Gut 66:633–643. doi:10.1136/gutjnl-2015-309595
19. Tsoi H, Chu ESH, Zhang X, Sheng J, Nakatsu G, Ng SC, Chan AWH, Chan FKL, Sung JJY, Yu J (2017) Peptostreptococcus anaerobius induces intracellular cholesterol biosynthesis in colon cells to induce proliferation and causes dysplasia in mice. Gastroenterology 152:1419–1433.e5
20. Gao R, Gao Z, Huang L, Qin H (2017) Gut microbiota and colorectal cancer. Eur J Clin Microbiol Infect Dis 36(5):757–769
21. Gao R, Kong C, Huang L, Li H, Qu X, Liu Z, Lan P, Wang J, Qin H (2017) Mucosa-associated microbiota signature in colorectal cancer. Eur J Clin Microbiol Infect Dis. doi:10.1007/s10096-017-3026-4
22. Kostic AD, Gevers D, Pedamallu CS, Michaud M, Duke F, Earl AM, Ojesina AI, Jung J, Bass AJ, Tabernero J, Baselga J, Liu C, Shivdasani RA, Ogino S, Birren BW, Huttenhower C, Garrett WS, Meyerson M (2012) Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res 22(2):292–298
23. Abed J, Emgård JE, Zamir G, Faroja M, Almogy G, Grenov A, Sol A, Naor R, Pikarsky E, Atlan KA, Mellul A, Chaushu S, Manson AL, Earl AM, Ou N, Brennan CA, Garrett WS, Bachrach G (2016) Fap2 mediates Fusobacterium nucleatum colorectal adenocarcinoma enrichment by binding to tumor-expressed Gal-GalNAc. Cell Host Microbe 20(2):215–225
24. Kostic AD, Chun E, Robertson L, Glickman JN, Gallini CA, Michaud M, Clancy TE, Chung DC, Lochhead P, Hold GL, El-Omar EM, Brenner D, Fuchs CS, Meyerson M, Garrett WS (2013) Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe 14(2):207–215
25. Rubinstein MR, Wang X, Liu W, Hao Y, Cai G, Han YW (2013) Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/beta-catenin signaling via its FadA adhesin. Cell Host Microbe 14(2):195–206
26. Gouba N, Drancourt M (2015) Digestive tract mycobiota: a source of infection. Med Mal Infect 45(1–2):9–16
27. Sokol H, Leducq V, Aschard H, Pham HP, Jegou S, Landman C, Cohen D, Liguori G, Bourrier A, Nion-Larmurier I, Cosnes J, Seksik P, Langella P, Skurnik D, Richard ML, Beaugerie L (2017) Fungal microbiota dysbiosis in IBD. Gut 66:1039–1048
28. Monteiro-da-Silva F, Sampaio-Maia B, Pereira Mde L, Araujo R (2013) Characterization of the oral fungal microbiota in smokers and non-smokers. Eur J Oral Sci 121(2):132–135
29. Mukherjee PK, Chandra J, Retuerto M, Sikaroodi M, Brown RE, Jurevic R, Salata RA, Lederman MM, Gillevet PM, Ghannoum MA (2014) Oral mycobiome analysis of HIV-infected patients: identification of Pichia as an antagonist of opportunistic fungi. PLoS Pathog 10(3):e1003996
30. Krause R, Moissl-Eichinger C, Halwachs B, Gorkiewicz G, Berg G, Valentin T, Prattes J, Högenauer C, Zollner-Schwetz I (2017) Mycobiome in the lower respiratory tract—a clinical perspective. Front Microbiol 7:2169
31. Alonso R, Pisa D, Aguado B, Carrasco L (2017) Identification of fungal species in brain tissue from Alzheimer’s disease by next-generation sequencing. J Alzheimers Dis 58(1):55–67
32. Luan C, Xie L, Yang X, Miao H, Lv N, Zhang R, Xiao X, Hu Y, Liu Y, Wu N, Zhu Y, Zhu B (2015) Dysbiosis of fungal microbiota in the intestinal mucosa of patients with colorectal adenomas. Sci Rep 5:7980
33. Schoch CL, Seifert KA, Huhndorf S, Robert V, Spouge JL, Levesque CA, Chen W; Fungal Barcoding Consortium; Fungal Barcoding Consortium Author List (2012) Nuclear ribosomal internal transcribed spacer (ITS) region as a universal DNA barcode marker for Fungi. Proc Natl Acad Sci U S A 109(16):6241–6246
34. Liu W, Zhang J, Wu C, Cai S, Huang W, Chen J, Xi X, Liang Z, Hou Q, Zhou B, Qin N, Zhang H (2016) Unique features of ethnic Mongolian gut microbiome revealed by metagenomic analysis. Sci Rep 6:34826
35. Masella AP, Bartram AK, Truszkowski JM, Brown DG, Neufeld JD (2012) PANDAseq: paired-end assembler for illumina sequences. BMC Bioinformatics 13:31
36. Edgar RC (2010) Search and clustering orders of magnitude faster than BLAST. Bioinformatics 26(19):2460–2461
37. Cole JR, Wang Q, Fish JA, Chai B, McGarrell DM, Sun Y, Brown CT, Porras-Alfaro A, Kuske CR, Tiedje JM (2014) Ribosomal Database Project: data and tools for high throughput rRNA analysis. Nucleic Acids Res 42(Database issue):D633–D642
38. Lozupone C, Lladser ME, Knights D, Stombaugh J, Knight R (2011) UniFrac: an effective distance metric for microbial community comparison. ISME J 5(2):169–172
39. Kim YH, Min BH, Kim SJ, Choi HK, Kim KM, Chun HK, Lee H, Kim JY, Chang DK, Son HJ, Rhee PL, Rhee JC, Kim JJ (2010) Difference between proximal and distal microsatellite-unstable sporadic colorectal cancers: analysis of clinicopathological and molecular features and prognoses. Ann Surg Oncol 17(5):1435–1441
40. Strati F, Di Paola M, Stefanini I, Albanese D, Rizzetto L, Lionetti P, Calabrò A, Jousson O, Donati C, Cavalieri D, De Filippo C (2016) Age and gender affect the composition of fungal population of the human gastrointestinal tract. Front Microbiol 7:1227
41. Ott SJ, Kühbacher T, Musfeldt M, Rosenstiel P, Hellmig S, Rehman A, Drews O, Weichert W, Timmis KN, Schreiber S (2008) Fungi and inflammatory bowel diseases: alterations of composition and diversity. Scand J Gastroenterol 43(7):831–841
42. Mukherjee PK, Sendid B, Hoarau G, Colombel JF, Poulain D, Ghannoum MA (2015) Mycobiota in gastrointestinal diseases. Nat Rev Gastroenterol Hepatol 12(2):77–87
43. Hong G, Miller HB, Allgood S, Lee R, Lechtzin N, Zhang SX (2017) Use of selective fungal culture media increases rates of detection of fungi in the respiratory tract of cystic fibrosis patients. J Clin Microbiol 55(4):1122–1130
44. de Almeida Júnior JN, Hennequin C (2016) Invasive trichosporon infection: a systematic review on a re-emerging fungal pathogen. Front Microbiol 7:1629
45. Montoya AM, González GM, Martinez-Castilla AM, Aguilar SA, Franco-Molina MA, Coronado-Cerda E, Rosas-Taraco AG (2017) Cytokines profile in immunocompetent mice during Trichosporon asahii infection. Med Mycol. doi:10.1093/mmy/myx018
46. Kushima H, Tokimatsu I, Ishii H, Kawano R, Watanabe K, Kadota JI (2017) A new amino acid substitution at G150S in lanosterol 14-alpha demethylase (Erg11 protein) in multi-azole-resistant Trichosporon asahii. Med Mycol J 58(1):E23–E28
47. Angiolella L, Leone C, Rojas F, Mussin J, de Los Angeles Sosa M, Giusiano G (2017) Biofilm, adherence, and hydrophobicity as virulence factors in Malassezia furfur. Med Mycol. doi:10.1093/mmy/myx014
48. Yu YN, Yu TC, Zhao HJ, Sun TT, Chen HM, Chen HY, An HF, Weng YR, Yu J, Li M, Qin WX, Ma X, Shen N, Hong J, Fang JY (2015) Berberine may rescue Fusobacterium nucleatum-induced colorectal tumorigenesis by modulating the tumor microenvironment. Oncotarget 6(31):32013–32026
49. Zhang X, Zhao Y, Xu J, Xue Z, Zhang M, Pang X, Zhang X, Zhao L (2015) Modulation of gut microbiota by berberine and metformin during the treatment of high-fat diet-induced obesity in rats. Sci Rep 5:14405
50. Cong L, Liao Y, Yang S, Yang R (2017) In vitro activity of berberine alone and in combination with antifungal drugs against planktonic forms and biofilms of Trichosporon asahii. Mycopathologia. doi:10.1007/s11046-017-0119-7
51. Pande A, Non LR, Romee R, Santos CA (2017) Pseudozyma and other non-Candida opportunistic yeast bloodstream infections in a large stem cell transplant center. Transpl Infect Dis 19(2)
52. Ilahi A, Hadrich I, Goudjil S, Kongolo G, Chazal C, Léké A, Ayadi A, Chouaki T, Ranque S (2017) Molecular epidemiology of a Malassezia pachydermatis neonatal unit outbreak. Med Mycol. doi:10.1093/mmy/myx022
53. Prohić A, Jovović Sadiković T, Kuskunović-Vlahovljak S, Baljić R (2016) Distribution of Malassezia species in patients with different dermatological disorders and healthy individuals. Acta Dermatovenerol Croat 24(4):274–281
54. Cheikhrouhou F, Guidara R, Masmoudi A, Trabelsi H, Neji S, Sellami H, Makni F, Ayadi A (2017) Molecular identification of Malassezia species in patients with Malassezia folliculitis in Sfax, Tunisia. Mycopathologia 182:583–589
55. Celis AM, Vos AM, Triana S, Medina CA, Escobar N, Restrepo S, Wösten HA, de Cock H (2017) Highly efficient transformation system for Malassezia furfur and Malassezia pachydermatis using Agrobacterium tumefaciens-mediated transformation. J Microbiol Methods 134:1–6
56. Ianiri G, Averette AF, Kingsbury JM, Heitman J, Idnurm A (2016) Gene function analysis in the ubiquitous human commensal and pathogen Malassezia genus. mBio 7(6):e01853-16
57. Park M, Cho YJ, Lee YW, Jung WH (2017) Whole genome sequencing analysis of the cutaneous pathogenic yeast Malassezia restricta and identification of the major lipase expressed on the scalp of patients with dandruff. Mycoses 60(3):188–197
58. Selander C, Engblom C, Nilsson G, Scheynius A, Andersson CL (2009) TLR2/MyD88-dependent and -independent activation of mast cell IgE responses by the skin commensal yeast Malassezia sympodialis. J Immunol 182(7):4208–4216
59. Al-Yasiri MH, Normand AC, L’Ollivier C, Lachaud L, Bourgeois N, Rebaudet S, Piarroux R, Mauffrey JF, Ranque S (2016) Opportunistic fungal pathogen Candida glabrata circulates between humans and yellow-legged gulls. Sci Rep 6:36157
60. Rizzetto L, De Filippo C, Cavalieri D (2014) Richness and diversity of mammalian fungal communities shape innate and adaptive immunity in health and disease. Eur J Immunol 44(11):3166–3181